Lilly’s Obesity Pill Gets US Approval in Challenge to Novo (3)

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year.

Lilly’s once-daily pill, called Foundayo, was approved to help people shed pounds or maintain previous weight loss, the US Food and Drug Administration said in a statement.

The review process took less than four months thanks to a new FDA program designed to expedite access to promising medications that meet national priorities, offer innovative cures or address unmet medical needs.

Foundayo will be available on its direct-to-consumer platform LillyDirect, with shipments starting on ...